Clinical Trials on Platelet Activation in New Zealand
Total 267 results
-
FSD Pharma, Inc.TerminatedMast Cell Activation Syndrome | Mast Cell Activation Disorder IdiopathicCanada, United States
-
NYU Langone HealthWithdrawnGluteus Medius ActivationUnited States
-
Blueprint Medicines CorporationCompletedSystemic Mast Cell Activation | KIT D816V MutationUnited States, France, United Kingdom, Italy, Germany, Belgium, Spain, Switzerland
-
State University of New York at BuffaloEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Rowan UniversityCompletedExercise | Sedentary Behavior | MotivationUnited States
-
LightIntegra TechnologyCompletedPoor Platelet Transfusion OutcomeUnited States
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopaenic, IdiopathicUnited States, Australia, New Zealand
-
Blueprint Medicines CorporationRecruitingIndolent Systemic Mastocytosis | Monoclonal Mast Cell Activation SyndromeUnited States, Spain, Australia, France, Netherlands, Switzerland, Norway, United Kingdom, Austria, Belgium, Germany, Italy, Portugal
-
Protalex, Inc.TerminatedPhase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITPIdiopathic Thrombocytopenic Purpura (ITP)Australia, New Zealand
-
PfizerTerminatedHealthy | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Primary Immune ThrombocytopeniaSpain, United States, Belgium, United Kingdom, New Zealand
-
NYU Langone HealthCompletedPlatelet Aggregation DefectsUnited States
-
Weill Medical College of Cornell UniversityNovartisCompletedImmune Thrombocytopenia | Platelet DisorderUnited States
-
Institute of Liver and Biliary Sciences, IndiaRecruitingThrombocytopeniaIndia
-
Omeros CorporationCompletedThrombotic MicroangiopathiesUnited States, Belgium, Bulgaria, Hong Kong, Italy, Lithuania, Malaysia, New Zealand, Poland, Singapore, Taiwan, Thailand
-
Sobi, Inc.TerminatedThrombocytopeniaUnited States
-
Northwell HealthStaten Island University HospitalCompleted
-
University of RochesterRecruitingThrombocytopeniaUnited States
-
Memorial Sloan Kettering Cancer CenterAmgenCompletedIsolated Chemotherapy-induced ThrombocytopeniaUnited States
-
University of RochesterCompletedHealthy | Diabetes | Platelet FunctionUnited States
-
Imago BioSciences, Inc., a subsidiary of Merck...CompletedEssential ThrombocythemiaUnited States, Australia, New Zealand, United Kingdom, Hong Kong, Germany, Italy
-
Weill Medical College of Cornell UniversityColumbia University; New York Presbyterian HospitalCompletedAlloimmune Thrombocytopenia | Fetal Alloimmune ThrombocytopeniaUnited States
-
Imago BioSciences, Inc., a subsidiary of Merck...Active, not recruitingPrimary Myelofibrosis | Thrombocythemia, EssentialUnited States, Australia, Hong Kong, Germany, Italy, New Zealand, United Kingdom
-
U.S. Army Medical Research and Development CommandCompleted
-
Merck Sharp & Dohme LLCRecruitingEssential ThrombocythemiaIsrael, Australia, Hong Kong, Japan, New Zealand, Taiwan, Korea, Republic of, United States, Spain
-
Hamilton Health Sciences CorporationUniversity Health Network, Toronto; Dartmouth-Hitchcock Medical Center; Ottawa... and other collaboratorsTerminated
-
HealthCore-NERINational Heart, Lung, and Blood Institute (NHLBI); Transfusion Medicine/Hemostasis...CompletedThrombocytopeniaUnited States
-
Mary M. Gooley Hemophilia CenterCompletedHemophilia | vonWillebrand Disease | Platelet Coagulation DisordersUnited States
-
Eisai Inc.CompletedThrombocytopenia Related to Chronic Liver DiseaseUnited States
-
Novartis PharmaceuticalsCompletedTumors With CDK4/6 Pathway ActivationUnited States
-
Memorial Sloan Kettering Cancer CenterSanofiRecruitingBlood Cancer | Refractory Immune CytopeniasUnited States
-
HealthCore-NERINational Heart, Lung, and Blood Institute (NHLBI)CompletedHeparin Induced ThrombocytopeniaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLeukemia | Anemia | Thrombocytopenia | NeutropeniaUnited States
-
Terumo BCTbioBiomedical Advanced Research and Development AuthorityTerminatedHematologic Malignancies | Hypoproliferative ThrombocytopeniaUnited States
-
Arog Pharmaceuticals, Inc.CompletedNewly Diagnosed AML With FLT3 Activating MutationsUnited States
-
Washington University School of MedicineGateway for Cancer Research; Servier Hellas Pharmaceuticals Ltd.RecruitingClonal Cytopenia of Undetermined SignificanceUnited States
-
Weill Medical College of Cornell UniversityCompletedThrombotic Microangiopathy | Disorder Related to Bone Marrow TransplantationUnited States
-
GlaxoSmithKlineCompletedThrombocytopaeniaUnited States, Germany, Israel, Belgium, Finland, Ireland, Italy, Greece, India, Czech Republic, Hungary, Canada, Poland
-
Cogent Biosciences, Inc.RecruitingMastocytosis | Mastocytosis, Systemic | SSM | Mastocytosis, IndolentUnited States, Italy, Canada, Australia, Spain, Switzerland, Norway, United Kingdom, Belgium, Poland, Netherlands, Germany, France, Czechia, Greece, Ireland
-
Eisai Inc.CompletedImmune Thrombocytopenia | Chronic ThrombocytopeniaPoland, Ukraine, Belgium, Bulgaria, South Africa, Netherlands, New Zealand, Singapore, Australia, Slovakia, Czechia
-
Memorial Sloan Kettering Cancer CenterTel-Aviv Sourasky Medical Center; AmgenActive, not recruitingThrombocytopenia | Lymphoma PatientsUnited States
-
Institute of Liver and Biliary Sciences, IndiaCompletedSpontaneous Reactivation of Hepatitis BIndia
-
St. Francis Hospital, New YorkUnknownCoronary Artery Disease | Platelet Aggregation Inhibitors | PCI- Percutaneous Coronary InterventionUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingClonal Cytopenia of Undetermined Significance | CCUS Clonal Cytopenia of Undetermined SignificanceUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLeukemia | Anemia | Thrombocytopenia | NeutropeniaUnited States
-
Sobi, Inc.TerminatedThrombocytopeniaUnited States
-
HealthCore-NERINational Heart, Lung, and Blood Institute (NHLBI)TerminatedThrombocytopeniaUnited States
-
Marina KremyanskayaRecruitingEssential Thrombocythemia | Myelofibrosis | MPNUnited States
-
Blueprint Medicines CorporationActive, not recruitingIndolent Systemic MastocytosisCanada, United States, Spain, United Kingdom, Germany, Belgium, Switzerland, Italy, Netherlands, Denmark, France, Norway, Sweden
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopaenic, IdiopathicThailand, Korea, Republic of, United Kingdom, New Zealand, Germany, Greece, Hong Kong, Pakistan, Poland, Romania, Russian Federation, Slovenia, Taiwan
-
Rockefeller UniversityNational Heart, Lung, and Blood Institute (NHLBI)RecruitingGlanzmann ThrombastheniaUnited States